Edgestream Partners L.P. Purchases New Position in Maximus, Inc. (NYSE:MMS)

Edgestream Partners L.P. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,608 shares of the health services provider's stock, valued at approximately $568,000.

Other large investors have also recently made changes to their positions in the company. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank bought a new stake in shares of Maximus in the fourth quarter worth about $29,000. V Square Quantitative Management LLC increased its holdings in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd bought a new stake in shares of Maximus in the fourth quarter worth about $54,000. Finally, IFP Advisors Inc increased its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Trading Up 0.3 %

NYSE MMS traded up $0.22 during trading hours on Friday, hitting $67.06. 457,007 shares of the company were exchanged, compared to its average volume of 481,849. The stock has a 50-day moving average price of $72.01 and a 200 day moving average price of $79.39. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The stock has a market cap of $3.80 billion, a PE ratio of 14.42 and a beta of 0.71.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Analyst Ratings Changes

MMS has been the topic of several research reports. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Insider Buying and Selling at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Bruce Caswell bought 3,500 shares of the company's stock in a transaction on Tuesday, December 17th. The shares were acquired at an average price of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.60% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.